Mechanism experiments have shown that in NSCLC cells treated with Z-guggulsterone, the upregulation of PD-L1 is partially mediated by farnesoid X receptor (FXR) inhibition, and partially by activating the Akt and Erk1/2 signaling pathways. This evidence concerns the gene NR1H4 and non-small cell lung carcinoma.